相关实验视频
Updated: May 25, 2025

08:31
Acellular and Cellular Lung Model to Study Tumor Metastasis
Published on: August 19, 2018
7.5K
尿代谢物模型用于预测肺癌患者的死亡过程
Séamus Coyle1,2, Elinor Chapman3, David M Hughes4
1Liverpool Head and Neck Cancer Centre, University of Liverpool, Liverpool, UK. s.coyle@liverpool.ac.uk.
Communications medicine
|February 27, 2025
概括
一个新的尿路代谢物模型准确地预测肺癌患者的死亡时间,提前30天. 这一生命终端护理的突破为临终患者提供了更好的识别和及时干预.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
背景情况:
- 准确地识别死亡对于终身护理至关重要,但目前的预测方法往往不准确,在死亡发生前几天才确定死亡.
- 提高识别死亡过程的及时性可以显著提高患者体验和护理质量.
研究的目的:
- 开发一种预测模型,用于识别生命的最后30天内正在死亡的患者.
- 在肺癌患者中利用尿道代谢学来建立一种新的预后工具.
主要方法:
- 对肺癌患者进行了尿道代谢学分析.
- 开发了一个基于7个尿路代谢物组的预测模型.
- 在不同的培训和验证队伍中验证了模型的准确性.
主要成果:
- 在两个队列中,7代谢物模型在多个时间点 (5,10,20,30天) 显示出出色的预测准确性 (AUC 0.83-0.90).
- 该模型在准确性和预测时间范围方面显著优于现有验证的预测工具.
- 确定了125种代谢物,在生命的最后四周,特别是在最后一周,出现了显著的变化.
结论:
- 鉴定出的代谢物为癌症患者死亡过程所影响的生物学途径提供了新的见解.
- 这些发现表明,由于保存的死亡轨迹,该模型在各种癌症类型中的潜在适用性.
- 基于这些代谢物的预后测试可以使临终患者的早期识别成为可能,从而改善临床实践和终身护理.
相关概念视频
One-Compartment Open Model: Urinary Excretion Data and Determination of k
119
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
119
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
24
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
24

